A citation-based method for searching scientific literature

Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger, John K Chan, Susan A Davidson, Robert S Mannel, Paul A DiSilvestro, Heather A Lankes, Nilsa C Ramirez, Mary Claire King, Elizabeth M Swisher, Michael J Birrer. JAMA Oncol 2016
Times Cited: 331



. Nature 2011
Times Cited: 4478




List of shared articles



Times cited

The current landscape of molecular profiling in the treatment of epithelial ovarian cancer.
Carolyn E Haunschild, Krishnansu S Tewari. Gynecol Oncol 2021
3

Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers.
Lorenzo Ceppi, Tommaso Grassi, Francesca Galli, Alessandro Buda, Giovanni Aletti, Andrea Alberto Lissoni, Marco Adorni, Annalisa Garbi, Nicoletta Colombo, Cristina Bonazzi,[...]. Gynecol Oncol 2021
0

Clinical impact of BRCA2 mRNA expression in high-grade serous ovarian cancer: validation using the TCGA cohort.
Irina Tsibulak, Verena Wieser, Hannah Welponer, Katharina Leitner, Hubert Hackl, Christian Marth, Heidelinde Fiegl, Alain G Zeimet. Acta Oncol 2021
0

Impact of BRCA1/2 Mutations on the Efficacy of Secondary Cytoreductive Surgery.
Felipe Leonardo Estati, Rafaela Pirolli, Viviane Teixeira Loiola de Alencar, Adriana Regina Gonçalves Ribeiro, Maria Nirvana Formiga, Giovana Tardin Torrezan, Dirce Maria Carraro, Andrea Paiva Gadelha Guimarães, Glauco Baiocchi, Alexandre André Balieiro Anastácio da Costa. Ann Surg Oncol 2021
3

FLABRA, frontline approach for BRCA testing in an ovarian cancer population: a Latin America epidemiologic study.
Gonzalo Giornelli, Dolores Gallardo, Roberto Hegg, Gonzalo Gomez Abuin, Maximo De La Vega, Maria Lim-Law, Valeria Caceres, Lina Trujillo, Maria Del Pilar Estevez-Diz, Cristian Pacheco,[...]. Future Oncol 2021
0

CAMK2N1/RUNX3 methylation is an independent prognostic biomarker for progression-free and overall survival of platinum-sensitive epithelial ovarian cancer patients.
Karolin Heinze, Matthias Rengsberger, Mieczyslaw Gajda, Lars Jansen, Linea Osmers, Leticia Oliveira-Ferrer, Barbara Schmalfeldt, Matthias Dürst, Norman Häfner, Ingo B Runnebaum. Clin Epigenetics 2021
1

Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer.
Jeffrey A How, Amir A Jazaeri, Bryan Fellman, Molly S Daniels, Suzanna Penn, Cara Solimeno, Ying Yuan, Kathleen Schmeler, Jerry S Lanchbury, Kirsten Timms,[...]. Cancers (Basel) 2021
2

Mutational spectrum in clinically aggressive low-grade serous carcinoma/serous borderline tumors of the ovary-Clinical significance of BRCA2 gene variants in genomically stable tumors.
Xiaoming Zhang, Kyle Devins, Emily M Ko, Maria Carolina Reyes, Fiona Simpkins, Ronny Drapkin, Lauren E Schwartz, Ju-Yoon Yoon. Gynecol Oncol 2021
0

Germline and tumor BRCA1/2 mutations in Chinese high grade serous ovarian cancer patients.
Gang Ji, Qianlan Yao, Longlong Bao, Jing Zhang, Qianming Bai, Xiaoli Zhu, Xiaoyu Tu, Rui Bi, Xiaoyan Zhou. Ann Transl Med 2021
0


Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance.
Rachel M Hurley, Cordelia D McGehee, Ksenija Nesic, Cristina Correia, Taylor M Weiskittel, Rebecca L Kelly, Annapoorna Venkatachalam, Xiaonan Hou, Nicholas M Pathoulas, X Wei Meng,[...]. NAR Cancer 2021
0

Epithelial ovarian cancer risk: A review of the current genetic landscape.
Nicola Flaum, Emma J Crosbie, Richard J Edmondson, Miriam J Smith, Dafydd G Evans. Clin Genet 2020
7

Exploring the Clinical Impact of Predictive Biomarkers in Serous Ovarian Carcinomas.
Cécile Le Page, Jacqueline Chung, Kurosh Rahimi, Martin Köbel, Diane Provencher, Anne-Marie Mes-Masson. Curr Drug Targets 2020
0

Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals.
Di Shao, Shaomin Cheng, Fengming Guo, Changbin Zhu, Yuying Yuan, Kunling Hu, Zhe Wang, Xuan Meng, Xin Jin, Yun Xiong,[...]. Cancer Sci 2020
6

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
41


Genetic testing for epithelial ovarian cancer.
Noa Amin, Narda Chaabouni, Angela George. Best Pract Res Clin Obstet Gynaecol 2020
1

Germline and Somatic BRCA1/2 Mutations in 172 Chinese Women With Epithelial Ovarian Cancer.
Yan You, Lei Li, Junliang Lu, Huanwen Wu, Jing Wang, Jie Gao, Ming Wu, Zhiyong Liang. Front Oncol 2020
4

Molecular Trajectory of BRCA1 and BRCA2 Mutations.
Yuichiro Hatano, Maho Tamada, Mikiko Matsuo, Akira Hara. Front Oncol 2020
16

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.
Solene De Talhouet, Julien Peron, Aurelie Vuilleumier, Alex Friedlaender, Valeria Viassolo, Aurélie Ayme, Alexandre Bodmer, Isabelle Treilleux, Noemie Lang, Jean- Christophe Tille,[...]. Sci Rep 2020
11

BRCA immunohistochemistry for screening of BRCA mutation in epithelial ovarian cancer patients.
Tarinee Manchana, Patou Tantbirojn, Natkrita Pohthipornthawat. Gynecol Oncol Rep 2020
0

Emerging drugs for the treatment of ovarian cancer: a focused review of PARP inhibitors.
Elizabeth K Lee, Ursula A Matulonis. Expert Opin Emerg Drugs 2020
1

The Landscape and Therapeutic Implications of Molecular Profiles in Epithelial Ovarian Cancer.
Ludivine Dion, Isis Carton, Sylvie Jaillard, Krystel Nyangoh Timoh, Sébastien Henno, Hugo Sardain, Fabrice Foucher, Jean Levêque, Thibault de la Motte Rouge, Susie Brousse,[...]. J Clin Med 2020
3